Joanna Mika

Title: Joanna Mika - Innovator in Neuropathic Pain Treatment

Introduction

Joanna Mika is a distinguished inventor based in Cracow, Poland. She has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of neuropathic pain. Her innovative approach combines the mechanisms of opioid receptors and melanocortin type 4 receptors to enhance therapeutic efficacy.

Latest Patents

Joanna Mika holds a patent for her invention titled "Hybrid peptidomimetics for use in neuropathic pain." This invention pertains to novel hybrid peptidomimetics and a pharmaceutical composition that utilizes these compounds for treating neuropathic pain. The hybrid peptidomimetics consist of two components: an opioid receptor agonist and a MC4 receptor antagonist, linked together. This unique structure allows for the activation of opioid receptors while simultaneously blocking melanocortin type 4 receptors, thereby improving the effectiveness of opioid therapy in managing neuropathic pain. She has 1 patent to her name.

Career Highlights

Throughout her career, Joanna Mika has worked with notable institutions, including the University of Warsaw and the Institute of Pharmacology of the Polish Academy of Sciences. Her work has been pivotal in advancing research in pain management and pharmacology.

Collaborations

Joanna has collaborated with esteemed colleagues such as Aleksandra Misicka-Kesik and Ewa Witkowska, contributing to the development of innovative solutions in her field.

Conclusion

Joanna Mika's contributions to the field of neuropathic pain treatment through her innovative patent demonstrate her commitment to advancing medical science. Her work continues to inspire future research and development in pharmacology.